Taysha’s $75M offering; Augustine raises €17M

Plus, news about Agile Therapeutics, Insud, Werewolf Therapeutics and Allakos:

Taysha Gene Therapies sells $75M in shares: The biotech is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Liquidia scores only tentative approval for Yutrepia due to Tyvaso exclusivity

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 20, 2024

Racial discrimination may exacerbate obesity risk in children

Children who experience racial discrimination are more likely to later have a higher body mass index (BMI) and larger waistline, according to a new study

July 11, 2023

Why very few people who are eligible for a cochlear implant actually get one

Cochlear implants have successfully improved hearing loss for decades, but few people who qualify for an implant actually get it. Even in countries with universal

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.